CryoPort Inc

Research CryoPort Inc (CYRX) on Bullrun: market cap USD 846.84M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 846.84M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 176.18MUSD 78.30M-USD 25.02M47.1%1.4USD 250.49MUSD 230.72MUSD 502.64M
FY2024USD 233.26M-USD 99.59M-USD 33.58M29.9%-2.49USD 34.14MUSD 242.54MUSD 401.90M
FY2023USD 237.28M-USD 37.33M-USD 39.54M31.7%-2.21USD 35.19MUSD 416.00MUSD 489.02M
FY2022USD 222.61M-USD 275.53M-USD 23.96M46.7%-0.93USD 29.23MUSD 430.65MUSD 555.84M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 846.84Mn/an/an/a
20252025-12-31USD 478.57Mn/an/an/a
20242024-12-31USD 388.29Mn/an/an/a
20232023-12-29USD 758.45Mn/an/an/a
20222022-12-30USD 850.15Mn/an/an/a
20212021-12-31USD 2.94Bn/an/an/a

About CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry.

Related stock research

Other Industrials stocks

Frequently asked questions

What is CryoPort Inc's market cap?

CryoPort Inc's market capitalization is USD 846.84M.

What does CryoPort Inc do?

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network.